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Abstract and Objective
Diabetes mellitus (DM) is a chronic disease affecting more 
than 285 people worldwide and the fourth leading cause of 
death. Increasing evidence suggests that many DM patients 
have poor adherence with prescribed medication therapies,
impacting clinical outcomes. Patients’ barriers to medication 
adherence and the extent to which barriers contribute to poor 
outcomes, however, are not routinely assessed. We designed a 
dashboard for an electronic health record system to integrate 
DM disease and medication data, including patient-reported 
barriers to adherence. Processes to support routine capture of 
data from patients are also being explored. The dashboard is 
being evaluated at multiple ambulatory clinics to examine 
whether integrated electronic tools can support patient-
centered decision-making processes involving complex medi-
cation regimens for DM and other chronic diseases.
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Introduction 
Diabetes mellitus (DM) is a chronic disease affecting more 
than 285 people worldwide and the fourth leading cause of 
death. Globally the prevalence of DM continues to rise at near-
ly epidemic rates, driven by urbanization, growing increases in 
obesity, and aging of populations.
Findings from several studies investigating the quality of DM 
care reveal a discrepancy between system-level disease man-
agement strategies and outcomes. In essence, even though 
there are improved treatment strategies, expected outcomes are 
not occurring at a commensurate level. Therefore greater em-
phases on patient-level factors that may explain DM interven-
tion outcomes are being explored.
One such factor is adherence to complex medication regimens. 
Increasing evidence suggests that patients with diabetes often 
have poor adherence with prescribed medication therapies.
However, patient barriers to medication adherence and the 
extent to which barriers contribute to poor DM outcomes is not
currently being assessed routinely in clinical practice.
Our project aims to electronically capture and present infor-
mation to clinicians regarding DM patients’ disease manage-
ment, medication adherence, and perceived barriers to adher-
ence. By integrating information at the point-of-care, we seek
to better inform DM therapy decision-making processes.
Methods
We designed a dashboard to electronically integrate relevant 
information from three distinct sources: 1) physiologic values 
from an electronic health record (EHR); 2) pharmacy claims 
information from a national data warehouse; and 3) patient 
self-reported barriers to medication adherence. The patient 
reported data was entered into an online e-health application, 
OpenMRS (www.openmrs.org), used globally in over 100 
nations for EHR management.
The dashboard was deployed within an EHR system used by 
primary care clinicians at urban clinics in Indianapolis, Indi-
ana. The dashboard will be evaluated during a six month pilot 
study which began in March 2013.
During the study, patients’ physiologic data (e.g., HbA1c, 
blood pressure), medication adherence rates, and self-reported 
barriers to adherence will be collected. The barriers data will 
be collected using a short, validated questionnaire [1]. We will 
further collect feedback from patients and clinicians regarding 
conversations about medication adherence as well as usability 
of the DM dashboard.
Conclusions
This is the first study to assess medication adherence by com-
bining patient medication history data from a combination of 
electronic data sources with subjects’ responses to a short val-
idated questionnaire that assesses possible barriers to medica-
tion adherence. It is further a novel examination of a clinical 
dashboard for delivering targeted, context-specific decision 
support to an integrated primary care team.
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